Given the drugs impact on reducing appetites and calorie intake, increasing AOM prevalence can shape demand for food, beverages and restaurants, and we anticipate meaningful impact in areas such as packaged food and beverages, restaurants, grocery stores and weight loss programs. While its early days, AOM patients report a 23% reduction in daily meals and 50% reduction in snacks, according to Morgan Stanley
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
Bottom Line Rybelsus : The new R2 dosing regimen improves tolerability while maintaining efficacy and supports potential future cardiovascular indications
Ozempic (lower-dose semaglutide) If you're using Ozempic for diabetes (typically 0.5-1.0 mg weekly), you're less likely to experience fatigue
ROS produced by NADPH oxidase activity was related to chemokine (CCL2, CXCL8, and CXCL10) production, and it was inhibited by the treatment of astrocytes with NAC or NADPH oxidase inhibitors [58]